[1] BURY L,MEGY K,STEPHENS J C,et al.Next-generation sequencing for the diagnosis of MYH9-RD:predicting pathogenic variants[J].Hum Mutat,2020,41(1):277-290. [2] 胡玉,马静瑶,刘会青,等.儿童MYH9相关疾病七例临床及遗传学特点分析[J].中华儿科杂志,2021,59(11):968-972. [3] 关祎童,张蕊,吴润晖,等.儿童遗传性血小板减少症的研究进展[J].国际儿科学杂志,2022,49(9):577-581. [4] ZANINETTI C,BAROZZI S,BOZZI V,et al.Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia[J].Am J Hematol,2019,94(8):E199-E201. [5] LI J,RONG L C,WANG J,et al.Umbilical cord blood transplantation for MYH9-related disorders[J].Pediatr Blood Cancer,2022,69(11):e29711. [6] EDDINGER T J,MEER D P.Myosin II isoforms in smooth muscle:heterogeneity and function[J].Am J Physiol Cell Physiol,2007,293(2):C493-C508. [7] PAL K,NOWAK R,BILLINGTON N,et al.Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease[J].Blood,2020,135(21):1887-1898. [8] PECCI A,KLERSY C,GRESELE P,et al.MYH9-related disease:a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations[J].Hum Mutat,2014,35(2):236-247. [9] 李卫滨,兰小鹏.MYH9异常的实验室和临床诊断策略[J].中华检验医学杂志,2013,36(5):475-478. [10] PECCI A,GRANATA A,FIORE C E,et al.Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)[J].Nephrol Dial Transplant,2008,23(8):2690-2692. [11] PEDDU D,AMIN S,YING Y L M.Characterization of sensorineural hearing loss in patients with MYH9-related disease:a systematic review[J].Otol Neurotol,2021,43(3):e298-e308. [12] PECCI A,BIINO G,FIERRO T,et al.Alteration of liver enzymes is a feature of the MYH9-related disease syndrome[J].PLoS One,2012,7(4):e35986. [13] PECCI A,MA X F,SAVOIA A,et al.MYH9:structure,fun ctions and role of non-muscle myosin IIA in human disease[J].Gene,2018,664:152-167. [14] 张丽宁,孙蕾,匡新宇,等.儿童散发性MYH9相关疾病1例报告[J].临床儿科杂志,2022,40(8):623-626. [15] 罗小娟,曹科,刘景,等.MYH9相关疾病六个家系临床特征和基因变异分析[J].中华儿科杂志,2021,59(11):957-962. [16] PECCI A,PANZA E,PUJOL-MOIX N,et al.Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease[J].Hum Mutat,2008,29(3):409-417. [17] GUO X,LIAN X Q,ZHANG W C,et al.A D1424N mutate on in the MYH9 gene results in macrothrombocytopenia and granulocytic inclusion bodies in a Chinese inherited macrothrombocytopenia pedigree[J].Clin Chem Lab Med CCLM,2018,56(7):e171-e173. [18] 儿童原发性免疫性血小板减少症诊疗规范(2019年版)[J].全科医学临床与教育,2019,17(12):1059-1062. [19] 吴晓勇,王云龙.免疫性血小板减少症相关性疲劳[J].临床医学进展,2020(9):2162-2168. [20] 张姮,魏宇婷,方拥军.原发性免疫性血小板减少症儿童生活质量及其影响因素研究进展[J].中国实用儿科杂志,2021,36(2):99-103. [21] ALBERT M H,SLATTER M A,GENNERY A R,et al.Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome:an EBMT Inborn ErrorsWorking Party analysis[J].Blood,2022,139(13):2066-2079. [22] BAKANE A,RAUTHAN A,MADASU A,et al.Successful T-cell-depleted haploidentical hematopoietic stem cell transplant for a novel NF-E2 mutation causing inherited thrombocytopenia[J].Pediatr Blood Cancer,2021,68(4):e28792. [23] BURROUGHS L M,PETROVIC A,BRAZAUSKAS R,et al.Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome:a PIDTC report[J].Blood,2020,135(23):2094-2105. |